RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, announces that it has completed the acquisition of iCAD, Inc. (NASDAQ: ICAD) (“iCAD”), a global leader in AI-powered breast health solutions. The integration of iCAD’s complementary commercial, technology, and regulatory capabilities into DeepHealth advances DeepHealth’s mission to address clinical and operational challenges in screening and diagnosis by harnessing the power of AI and imaging. iCAD’s extensive AI portfolio—including breast cancer detection, risk evaluation, breast density, and breast arterial calcification assessment—is deployed in more than 50 countries.
Read the full article: RadNet’s Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCAD //
Source: https://www.globenewswire.com/news-release/2025/07/17/3117278/10985/en/RadNet-s-Wholly-Owned-Subsidiary-DeepHealth-Completes-Acquisition-of-iCAD.html